AbbVie Inc. (ABBV - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 9.2% in the past one-month time frame.
The company's Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for AbbVie. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
AbbVie currently has a Zacks Rank #3 (Hold) while its Earnings ESP is +1.48%.
AbbVie Inc. Price and Consensus
A better-ranked stock in the Large Cap Pharmaceuticals industry is Pfizer Inc. (PFE), which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is ABBV going up? Or down? Predict to see what others think: Up or Down
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>